1. Medtech Insight
  2. >>Geography
  3. >>Europe

What Changes To The AI Act Would Benefit Medtech Most?

 
• By Eliza Slawther

With the European Commission’s AI Act now in the final negotiation phase, industry bodies MedTech Europe and COCIR have outlined several areas where the draft text could be altered to optimize the potential of AI in health care.

AI Legislation
• Source: Shutterstock

European trade bodies MedTech Europe and COCIR have co-signed a letter with 11 other health organizations urging EU policymakers to “strongly consider” the impact the Artificial Intelligence (AI) Act proposal will have on the EU health ecosystem while firming up details of the final legislation.

Key Takeaways

Trilogue negotiations between the European Parliament, Commission and Council on the content of the draft AI Act began last month and represent the final opportunity for changes to be agreed to the draft text before the legislation is adopted.

During this process, the three entities will present their own versions of the draft text, and eventually reach a decision on the final unified version.

These discussions may go on for some 12-18 months, depending on how long it takes for an agreement to be reached on the details of the proposal.(Also see "EU AI Act Legal Deep-Dive Part 1: What Can Medtech Expect, And When?" - Medtech Insight, 7 June, 2023.)

A key priority during these trilogues, the stakeholders say in their letter, is ensuring the AI Act is aligned with...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Commission Decision Launches Pediatric And Rare Disease Expert Group

 
• By Amanda Maxwell

A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.

Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer Device

 
• By Natasha Barrow

Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

Finland Cracks Down On Software That Needs Regulating As A Medical Devices

 
• By Amanda Maxwell

Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it. 

Milner Pitch Day: Multiomic Pathology, Microcancer Avatars And Cell Morphology Intelligence

 
• By Natasha Barrow

The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.

More from Geography

Court Orders US FDA To Return Trial Diversity Action Plan Guidance To Website

 
• By Sue Sutter

HHS and its agencies violated the law by swiftly implementing “sweeping and poorly thought-through directives that ordered the bulk removal of healthcare resources,” including FDA draft guidances on diversity action plans and sex differences in clinical trials, a federal court said.

Planning To Take Part in MDUFA? FDA Wants To Hear From You

 
• By Brian Bossetta

The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.

Global Medtech Guidance Tracker: June 2025

 
• By Vibha Sharma

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.